Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Description

This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.

Conditions

Multiple Myeloma

Study Overview

Study Details

Study overview

This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.

Feasibility of a Prehabilitation Intervention Among Older Adults with Myeloma Receiving Autologous Stem Cell Transplant

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Condition
Multiple Myeloma
Intervention / Treatment

-

Contacts and Locations

Birmingham

Kirklin Clinic of UAB Hospital, Birmingham, Alabama, United States, 35294

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of Multiple Myeloma
  • * Scheduled for ASCT at UAB within 10 weeks of study enrollment
  • * age at ASCT ≥60y
  • * at high risk for impending pathologic fracture using Mirels score

Ages Eligible for Study

60 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Smith Giri,

Study Record Dates

2025-12-31